Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

about

Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.The use of sunitinib in renal cell carcinoma: where are we now?Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma.

P2860

Q38807483-6C86A67A-D7B6-4BA7-AD03-3A8671CCE04F Q48634468-D623B662-210C-44CD-BBB6-6630ADFE3795 Q52661758-3541E6A6-A4E8-4B6E-8C65-DE59208BC9A3

P2860

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

Item

http://www.wikidata.org/entity/Q37214287

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

@en

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma.

@nl

type

Item

label

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

@en

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma.

@nl

prefLabel

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

@en

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma.

@nl

P1476

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

@en

P2093

C Tarpin

http://www.w3.org/2001/XMLSchema#string

G Gravis

http://www.w3.org/2001/XMLSchema#string

J Thomassin

http://www.w3.org/2001/XMLSchema#string

M Cappiello

http://www.w3.org/2001/XMLSchema#string

M Gilabert

http://www.w3.org/2001/XMLSchema#string

M Provansal

http://www.w3.org/2001/XMLSchema#string

N Salem

http://www.w3.org/2001/XMLSchema#string

S Brunelle

http://www.w3.org/2001/XMLSchema#string

Y Walz

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity.

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Role of tyrosine kinase inhibitors in cancer therapy.

Oral complications of cancer therapy.

Management of oral mucositis in patients who have cancer

Sunitinib: from rational design to clinical efficacy.

Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer.

Symptom burden: multiple symptoms and their impact as patient-reported outcomes.

Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer.

P2888

bjc.2013.516

P304

1750-1754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.516

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256705123

http://www.w3.org/2001/XMLSchema#string

P698

24045668

http://www.w3.org/2001/XMLSchema#string

P932

3790170

http://www.w3.org/2001/XMLSchema#string

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

about

P2860

P2860

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932